Meta facebook tracking pixel

Listen Now

Topics Covered

  • Overview of HER2-Positive Metastatic Breast Cancer, in the Context of COVID-19
  • Biomarker, Genomic & Diagnostic Testing: Grade and Hormone Receptors
  • Standard Treatment Options, including Targeted Therapy
  • How Biomarker Testing Informs Treatment Decisions
  • New & Emerging Targeted Treatments
  • Updates on Investigational New Drugs in Clinical Trials
  • How Research Contributes to Your Treatment Options
  • What’s New in the Prevention & Management of Treatment Side Effects, Discomfort & Long-Term Effects
  • The Increasing Role of Telemedicine/Telehealth Appointments
  • Guidelines to Prepare for Telemedicine/ Telehealth Appointments, including Technology, List of Questions & OpenNotes Discussion
  • Key Questions to Ask Your Health Care Team about Quality-of-Life Concerns
  • Questions for Our Panel of Experts

Our Panel of Experts


Generosa Grana, MD, FACP

Medical Director, MD Anderson Cancer Center at Cooper, The Cooper Health System, Professor of Medicine, Cooper Medical School at Rowan University


Minetta C. Liu, MD

Professor and Research Chair, Division of Medical Oncology, Department of Oncology, Consultant, Division of Anatomic Pathology, Department of Laboratory Medicine and Pathology, Medical Director, Office of Specialty Collaborations and Contracts, Co-Leader, Genomics in Action Strategic Priority, Center for Individualized Medicine, Mayo Clinic


Sara A. Hurvitz, MD, FACP

Professor of Medicine, Director, Breast Cancer Clinical Trials Program, Division of Hematology-Oncology, David Geffen School of Medicine, UCLA, Medical Director, Clinical Research Unit, Jonsson Comprehensive Cancer Center


Jennifer M. Matro, MD

Associate Clinical Professor of Medicine, Division of Hematology/Oncology, University of California San Diego Health


Lauren Chatalian, MSW

Women & Children’s Program Manager, CancerCare


You can download the brochure for this workshop Download button

Workshop Date

This workshop was originally recorded on October 13, 2021.

Search by:



The information presented in this workshop is provided for your general information only. It is not intended as medical advice and should not be relied upon as a substitute for consultations with qualified health professionals who are aware of your specific situation. We encourage you to take information and questions back to your individual health care provider as a way of creating a dialogue and partnership about your cancer and your treatment.

Back to Top

Terms of Use and Privacy Policy

By using our website, you agree to our recently updated Privacy Policy . Here you can read more about our use of cookies which help us make continuous improvements to our website. Privacy Policy.